United Therapeutics
UTHR
$220.99
Share price
-0.23%
Change (1 day)
-3.30%
Change (1 year)
Categories
Revenue for United Therapeutics (UTHR)
Revenue in 2023 (TTM): $2.11 B
According to United Therapeutics's latest financial reports the company's current revenue (TTM) is $2.11 B. In 2022 the company made a revenue of $1.93 B an increase over the years 2021 revenue that were of $1.68 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for United Therapeutics from 2001 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $2.11 B | 9.02% |
| 2022 | $1.93 B | 14.88% |
| 2021 | $1.68 B | 13.63% |
| 2020 | $1.48 B | 2.38% |
| 2019 | $1.44 B | -11% |
| 2018 | $1.62 B | -5.65% |
| 2017 | $1.72 B | 7.91% |
| 2016 | $1.59 B | 9.08% |
| 2015 | $1.46 B | 13.76% |
| 2014 | $1.28 B | 15.36% |
| 2013 | $1.11 B | 21.93% |
| 2012 | $0.91 B | 22.75% |
| 2011 | $0.74 B | 23.59% |
| 2010 | $0.60 B | 63.26% |
| 2009 | $0.36 B | 31.39% |
| 2008 | $0.28 B | 33.45% |
| 2007 | $0.21 B | 32.14% |
| 2006 | $0.15 B | 37.71% |
| 2005 | $0.11 B | 57.51% |
| 2004 | $73.59 M | 37.96% |
| 2003 | $53.34 M | 77.09% |
| 2002 | $30.12 M | 425.5% |
| 2001 | $5.73 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $77.94 B | 3,592.45% | 🇺🇸 USA |
 Eli Lilly LLY | $29.51 B | 1,298.24% | 🇺🇸 USA |
 Baxter BAX | $15.01 B | 611.36% | 🇺🇸 USA |
 Gilead Sciences GILD | $27.38 B | 1,197.17% | 🇺🇸 USA |
 Cardinal Health CAH | $205.01 B | 9,612.07% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $35.34 B | 1,574.63% | 🇬🇧 UK |
 Cytokinetics
CYTK | $9.95 M | -99.53% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $15.01 B | 611.45% | 🇮🇱 Israel |